Antibiotics improve survival but not comfort for terminal dementia patients with pneumonia

July 12, 2010

BOSTON--A new study by scientists at the Institute for Aging Research of Hebrew SeniorLife says the use of antibiotics to treat pneumonia in patients with terminal dementia presents a "doubled-edged" sword for health-care providers and family members, finding that antibiotics may prolong survival for these patients, but do not improve their comfort.

"Survival was prolonged among patients who received antibiotics compared to those who were untreated," says lead author Jane L. Givens, M.D., M.S.C.E., an assistant scientist at the Institute for Aging Research. "At the same time, we found that antibiotics did not improve the comfort of these patients and that more aggressive forms of treatment may cause greater levels of discomfort."

A recent Institute study (New England Journal of Medicine, Oct. 15, 2009) was the first to rigorously describe the clinical course of advanced dementia, finding that the disease's pattern of distressing symptoms is similar to those experienced by patients dying of more commonly recognized terminal conditions such as cancer.

An estimated 5 million Americans have dementia. Infections, particularly pneumonia, are common in advanced dementia, especially toward the end of life, with nearly one in four decisions facing families of nursing home patients concerning the treatment of these infections. These decisions, says Dr. Givens, are ideally guided by the goals of care, which for some may be prolonging life and for others may be comfort. Families and caregivers, however, often do not have sufficient information to assess the effectiveness of treatment options.

The study, published in the July 12 issue of the Archives of Internal Medicine, analyzed data from 323 nursing home residents with terminal dementia in 22 Boston area facilities as part of the "Choices, Attitudes and Strategies for Care of Advanced Dementia at End-of-Life" (CASCADE) study. Each resident was followed for up to 18 months or until their death. Antibiotic treatment for each suspected pneumonia episode was characterized as none, oral only, intramuscular injection only, or either intravenous treatment or hospitalization. A majority of patients (55%) received oral antibiotics, while only 9 percent reported taking none. Fifteen percent received intramuscular injections and 20 percent received intravenous antibiotics or were hospitalized. Survival and comfort were assessed using common measurement scales.

According to the study, antibiotic treatment was associated with longer survival after suspected pneumonia episodes compared to no treatment. Comfort, however, was highest among those not treated with antibiotics and was progressively lower as the aggressiveness of care increased (i.e., those taking either intravenous or intramuscular antibiotics were in greater discomfort).

"Our findings have important implications for clinical practice," says Dr. Givens, an instructor in medicine at Harvard Medical School. "The management of infections, especially pneumonia, is one of the common decisions confronting families and practitioners. For these patients, our results indicate that antibiotic treatment for suspected pneumonia may be a double-edged sword, as it is associated with both survival and discomfort. Our observations may help families and providers align the potential advantages and disadvantages of antibiotic treatment with their goals of care."

When the primary goal of treatment is survival, Dr. Givens says providers and families should consider limiting treatment to oral antibiotics (or intramuscular injections if oral administration is not possible) because they appear to achieve the same survival benefit as more aggressive forms of antibiotic treatment, but with potentially fewer complications. When the goal is comfort, she recommends that antibiotics be withheld and that palliative care, also called comfort care, be provided.
-end-
The study was funded by the National Institute on Aging and a Hartford Geriatrics Health Outcomes Research Scholars Award to Dr. Givens.

Scientists at the Institute for Aging Research of Hebrew SeniorLife seek to transform the human experience of aging by conducting research that ensures a life of health, dignity and productivity into advanced age. The Institute carries out rigorous medical and social studies that discover the mechanisms of age-related disease and disability; lead to the prevention, treatment and cure of disease; advance the standard of care for older people; and inform public decision-making.

Founded in 1903, Hebrew SeniorLife, an affiliate of Harvard Medical School, is a nonprofit, non-sectarian organization devoted to innovative research, health care, education and housing that improves the lives of seniors.

Hebrew SeniorLife Institute for Aging Research

Related Dementia Articles from Brightsurf:

The danger of Z-drugs for dementia patients
Strong sleeping pills known as 'Z-drugs' are linked with an increased risk of falls, fractures and stroke among people with dementia, according to new research.

The long road to dementia
Alzheimer's disease develops over decades. It begins with a fatal chain reaction in which masses of misfolded beta-amyloid proteins are produced that in the end literally flood the brain.

Why people with dementia go missing
People with dementia are more likely to go missing in areas where road networks are dense, complicated and disordered - according to new research from the University of East Anglia.

PTSD may double risk of dementia
People who have experienced post-traumatic stress disorder (PTSD) are up to twice as likely to develop dementia later in life, according to a new study by UCL researchers, published in the British Journal of Psychiatry.

Dementia education
School-based dementia education could deliver much needed empathy and understanding for older generations as new research from the University of South Australia shows it can significantly improve dementia knowledge and awareness among younger generations.

Building dementia friendly churches
A project to help church communities become more 'dementia friendly' has had a significant impact across the country.

A "feeling" for dementia?
A research team led by the DZNE concludes that personal perception can be an important indicator for the early detection of Alzheimer's disease.

New biomarker for dementia diagnosis
Medical researchers in the UK and Australia have identified a new marker which could support the search for novel preventative and therapeutic treatments for dementia.

Digital solutions for dementia care
Telehealth delivery of dementia care in the home can be as effective as face-to-face home visit services if carers and recipients take advantage of the technologies available, Australian researchers say.

Despite a marked reduction in the prevalence of dementia, the number of people with dementia is set to double by 2050 according to new Alzheimer Europe report
Today, at a European Parliament lunch debate, Alzheimer Europe launched a new report presenting the findings of its collaborative analysis of recent prevalence studies and setting out updated prevalence rates for dementia in Europe.

Read More: Dementia News and Dementia Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.